Dahl L E, Dencker S J, Lundin L, Kullingsjö H
Acta Psychiatr Scand. 1982 Feb;65(2):86-92. doi: 10.1111/j.1600-0447.1982.tb00826.x.
The short-acting hypnotic, triazolam 0.5 mg, was compared in a 7-day double-blind study with the longer acting drug, nitrazepam 5 mg. Of the 60 patients enrolled, 29 in each drug treatment group completed the study and were evaluated. All significant differences found favoured triazolam. On the first night, triazolam was found to be significantly more effective than nitrazepam in inducing and maintaining sleep and in increasing its overall duration. The patients' subjective preference, reflecting the depth of sleep experienced and the effect of the medication, reached highly significant levels in favour of triazolam. Later in the study the differences between the drugs disappeared although the depth of sleep as judged in the study was better with triazolam.
在一项为期7天的双盲研究中,将短效催眠药三唑仑0.5毫克与长效药物硝西泮5毫克进行了比较。在纳入的60名患者中,每个药物治疗组有29名患者完成了研究并接受了评估。发现的所有显著差异均有利于三唑仑。在第一个晚上,发现三唑仑在诱导和维持睡眠以及延长其总时长方面比硝西泮显著更有效。患者的主观偏好反映了所体验到的睡眠深度和药物的效果,高度显著地倾向于三唑仑。在研究后期,尽管根据研究判断三唑仑的睡眠深度更好,但两种药物之间的差异消失了。